Home » Power3 Files Provisional Patent Application for Biomarker-Based Method
Power3 Files Provisional Patent Application for Biomarker-Based Method
May 10, 2005
Power3 Medical Products announced it has filed a provisional patent application with the U.S. Patent and Trademark Office for the company's first generic, blood-based diagnostic test for neuromuscular disorders such as ALS and Parkinson's disease. The patent application is being filed in conjunction with major research institutions in the Houston, Texas, area, with Power3 having an exclusive license to commercialize the technology involved.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-09-2005/0003590103&EDATE=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct